A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice
Study Identifier
P19-287
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will evaluate effectiveness and safety in routine clinical practice in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).
Study Locations
Location
Status
Location
Soroka University Medical Center /ID# 207897
Beersheba, Southern District, Israel, 8443901
Status
Not applicable
Location
The Chaim Sheba Medical Center /ID# 207900
Ramat Gan, Tel Aviv, Israel, 5265601
Status
Not applicable
Location
Tel Aviv Sourasky Medical Center /ID# 206962
Tel Aviv, Tel Aviv, Israel, 6423906
Status
Not applicable
Location
HaEmek Medical Center /ID# 210900
Afula, Israel, 1834111
Status
Not applicable
Location
Rambam Health Care Campus /ID# 210320
Haifa, Israel, 3109601
Status
Not applicable
Location
Bnai Zion Medical Center /ID# 206963
Haifa, Israel, 3339419
Status
Not applicable
Showing {first} - {last} of {total} Results